Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

Stopped No longer have funding support to complete the pharmacogenetics component.

Conditions

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Interventions

• DRUG: Cladribine, Cytarabine, Mitoxantrone, G-CSF (CLAG-M) regimen
• DRUG: Cladribine and Cytarabine (CLLDAC) Regimen

Sponsor

Medical College of Wisconsin